BOLT Stock Price History and Quote Analysis Insights for Investors

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own BOLT shares is 41, representing 58.19% of the company's common stock.

CITIGROUP INC, in the last quarter, reduced its stake in BOLT by -100% restricting it's holding to 0 shares of worth nearly -. BLACKROCK INC. also lessened -0.9% of the BOLT shares from its portfolio, reducing its holding to 254.96 thousand shares of worth $356.94K. JANE STREET GROUP, LLC also shunned BOLT shares holding by -100% last quarter which brought its holding to 0 shares worth -.

As per its latest 13F filing, VANGUARD GROUP INC increased its stake in BOLT by 11.43% in the last quarter. The institutional holder raised its holding to 1.04 million shares having worth more than $1.45M. ADAR1 CAPITAL MANAGEMENT, LLC also added 100% more shares of BOLT to its portfolio, raising its holding to 5 thousand shares of worth $7.00K. WELLS FARGO & COMPANY/MN also increased its BOLT shares holding by 1.93% which brought its holding to 211 shares worth $295.00.

The insider with the most stakes in BOLT is N/A , N/A at the company. Additionally, BOLT stock is highly held by N/A N/A and N/A N/A among others.

Company executives, directors, and other insiders own 3.46% percent of Bolt Biotherapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which BOLT insiders have sold stock, totaling 0 shares. Insiders that have sold shares include ENGLEMAN EDGAR, VIVO CAPITAL VIII, LLC, and NOVO HOLDINGS A/S.

There have been 0 transaction(s) during the past 6-months in which Bolt Biotherapeutics, Inc. insiders have bought stock, totalling 0 shares

Around 0 Bolt Biotherapeutics, Inc. shares are held by insiders, which represents about 3.46% of BOLT stock.

BOLT N/A, N/A holds the largest portfolio of the company's shares. BOLT shares owned by N/A total nearly -.

CITIGROUP INC is the largest institutional owner in BOLT which holds 0 shares worth - or 0% of the total BOLT shares outstanding followed by VIVO CAPITAL, LLC with ownership of 3.52 million shares representing 9.31% of the BOLT ownership. PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC is the third largest stakeholder with 1.89 million shares or 5% of the ownership worth more than $2.65M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the BOLT is concerned, it is a stock which is not optionable.

Number of BOLT shares short is 119.45K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 38.26M shares of BOLT are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, BOLT has 25.04M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for BOLT is 0.86.